Related Experiment Videos
Gynecological abnormalities following allogeneic bone marrow transplantation
M A Schubert1, K M Sullivan, M M Schubert
1Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Bone Marrow Transplantation
|June 1, 1990
Summary
Bone marrow transplant recipients frequently experience gynecological issues, particularly after total body irradiation (TBI). Early hormone replacement therapy can significantly improve quality of life for these patients.
Area of Science:
- Gynecology
- Hematology
- Oncology
Background:
- Allogeneic bone marrow transplantation is a life-saving procedure.
- Graft-versus-host disease and treatment regimens can lead to long-term complications.
- Gynecological health is a critical aspect of post-transplant recovery and quality of life.
Purpose of the Study:
- To investigate the prevalence and nature of gynecological abnormalities in women post-allogeneic bone marrow transplantation.
- To assess the impact of total body irradiation (TBI) on these abnormalities.
- To inform clinical practice regarding early detection and management.
Main Methods:
- Study included 44 post-pubertal women 261-4628 days after transplantation.
- Evaluations comprised pelvic exams, cytology, hormone levels, and microbial cultures.
- Comparison between patients who received TBI and those who did not.
Main Results:
- 80% of women (35/44) exhibited gynecological abnormalities, primarily atrophic changes.
- Total body irradiation (TBI) was significantly associated with these abnormalities (33/36 TBI recipients vs. 2/8 non-TBI; p=0.02).
- Elevated gonadotropin levels indicated TBI-induced ovarian failure; vasomotor symptoms were more common in TBI recipients.
Conclusions:
- Gynecological abnormalities are common after bone marrow transplantation, especially with TBI.
- These findings suggest TBI-induced ovarian failure.
- Early recognition and hormone replacement therapy are recommended to improve patient well-being.